METHODS	Treatment-nave patients ( N = 237 ) were randomly assigned to groups given 12 weeks of danoprevir ( 300 mg every 8 hours ; 600 mg every 12 hours , and 900 mg every 12 hours ) or placebo plus peginterferon alfa-2a and ribavirin , followed by peginterferon alfa-2a and ribavirin .\